HODO · House of Doge Inc. · Insider Trading
Substantial doubt about the company's ability to continue as a going concern.
“These conditions and events, considered in the aggregate, raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these financial statements are issued. Management believes that these plans are designed to provide additional liquidity and support the continuation of the Company's operations. However, the Company's ability to obtain additional capital, monetize investments and achieve anticipated operating improvements is subject to conditions and uncertainties that are not entirely within its control. Accordingly, management concluded that its plans do not alleviate the substantial doubt about the Company's ability to continue as a going concern within one year after the date these unaudited interim condensed consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-03-18 | Malloy Lavell Juan II |
Director, Chairman and CEO |
Other↓
Filing footnotes — Restricted Stock Unit (Direct)
The RSUs do not expire, they either vest or are canceled prior to vesting date. |
Restricted Stock Unit
|
570,778 |
| 2026-03-18 | Malloy Lavell Juan II |
Director, Chairman and CEO |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
347,222 of the stock options had an exercise price of $0.576 per share, were exercisable in accordance with the vesting schedule, and were set to expire on March 5, 2035. The remaining 223,556 stock options had an exercise price of $1 per share, were exercisable immediately and were set to expire on July 18, 2030. On March 18, 2026, the Board of Directors (the "Board") approved a corrective action whereby the Company and the Reporting Person agreed to mutually cancel all outstanding stock option awards held by the Reporting Person, consisting of 570,778 shares subject to the options held and issue 570,778 restricted stock units ("RSUs") in lieu of the number of shares underlying the cancelled stock options. |
Stock Option (right to buy)
|
570,778 |
| 2026-03-18 | Leibovich Daniel |
Director, Chief Operating Officer |
Other↓
Filing footnotes — Restricted Stock Unit (Direct)
The RSUs do not expire, they either vest or are canceled prior to vesting date. |
Restricted Stock Unit
|
570,778 |
| 2026-03-18 | Malloy Lavell Juan II |
Director, Chairman and CEO |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
The RSUs do not expire, they either vest or are canceled prior to vesting date. |
Restricted Stock Unit
|
570,778 |
| 2026-03-18 | Leibovich Daniel |
Director, Chief Operating Officer |
Award↑
Filing footnotes — Common Stock (Direct)
These securities are RSUs, which were issued pursuant to the Company's 2024 Omnibus Incentive Plan. The RSUs are fully vested and immediately exercisable. |
Common Stock
|
570,778 |
| 2026-03-18 | Malloy Lavell Juan II |
Director, Chairman and CEO |
Award↑
Filing footnotes — Common Stock (Direct)
These securities are RSUs, which were issued pursuant to the Company's 2024 Omnibus Incentive Plan. The RSUs are fully vested and immediately exercisable. |
Common Stock
|
570,778 |
| 2026-03-18 | Leibovich Daniel |
Director, Chief Operating Officer |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
347,222 of the stock options had an exercise price of $0.576 per share, were exercisable in accordance with the vesting schedule, and were set to expire on March 5, 2035. The remaining 223,556 stock options had an exercise price of $1 per share, were exercisable immediately and were set to expire on July 18, 2030. On March 18, 2026, the Board of Directors (the "Board") approved a corrective action whereby the Company and the Reporting Person agreed to mutually cancel all outstanding stock option awards held by the Reporting Person, consisting of 570,778 shares subject to the options held and issue 570,778 restricted stock units ("RSUs") in lieu of the number of shares underlying the cancelled stock options. |
Stock Option (right to buy)
|
570,778 |
| 2026-03-18 | Leibovich Daniel |
Director, Chief Operating Officer |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
The RSUs do not expire, they either vest or are canceled prior to vesting date. |
Restricted Stock Unit
|
570,778 |
| 2025-07-18 | Leibovich Daniel |
Director, Chief Operating Officer |
Award↑
Filing footnotes — Stock option (right to buy) (Direct)
On July 18, 2025, the Board of Directors of the Company granted the stock options ("Options"), which were issued pursuant to the Company's 2024 Omnibus Incentive Plan. The Options are fully vested, immediately exercisable and shall expire on July 18, 2030. |
Stock option (right to buy)
|
223,556 |
| 2025-07-18 | Foster Kevin |
Director |
Award↑
Filing footnotes — Stock option (right to buy) (Direct)
On July 18, 2025, the Board of Directors of the Company granted the stock options ("Options"), which were issued pursuant to the Company's 2024 Omnibus Incentive Plan. The Options are fully vested, immediately exercisable and shall expire on July 18, 2030. |
Stock option (right to buy)
|
150,000 |
| 2025-07-18 | Jindal Chetan |
Chief Financial Officer |
Award↑
Filing footnotes — Stock option (right to buy) (Direct)
On July 18, 2025, the Board of Directors of the Company granted the stock options ("Options"), which were issued pursuant to the Company's 2024 Omnibus Incentive Plan. The Options are fully vested, immediately exercisable and shall expire on July 18, 2030. |
Stock option (right to buy)
|
50,000 |
| 2025-07-18 | Jackson DeLu |
Director |
Award↑
Filing footnotes — Stock option (right to buy) (Direct)
On July 18, 2025, the Board of Directors of the Company granted the stock options ("Options"), which were issued pursuant to the Company's 2024 Omnibus Incentive Plan. The Options are fully vested, immediately exercisable and shall expire on July 18, 2030. |
Stock option (right to buy)
|
100,000 |
| 2025-07-18 | Fidrya Daniel |
Director |
Award↑
Filing footnotes — Stock option (right to buy) (Direct)
On July 18, 2025, the Board of Directors of the Company granted the stock options ("Options"), which were issued pursuant to the Company's 2024 Omnibus Incentive Plan. The Options are fully vested, immediately exercisable and shall expire on July 18, 2030. |
Stock option (right to buy)
|
100,000 |
| 2025-07-18 | Malloy Lavell Juan II |
Director, Chairman and CEO |
Award↑
Filing footnotes — Stock option (right to buy) (Direct)
On July 18, 2025, the Board of Directors of the Company granted the stock options ("Options"), which were issued pursuant to the Company's 2024 Omnibus Incentive Plan. The Options are fully vested, immediately exercisable and shall expire on July 18, 2030. |
Stock option (right to buy)
|
223,556 |
| 2025-06-24 | Jindal Chetan |
Chief Financial Officer |
Award↑
Filing footnotes — Stock option (right to buy) (Direct)
On June 24, 2025, the Board of Directors of the Company granted the stock options ("Options") which were issued pursuant to the Company's 2024 Omnibus Incentive Plan. Twenty-five percent (25%) of the Options vested on the issuance date, and twenty-five percent (25%) shall vest on each of June 24, 2026, June 24, 2027, and June 24, 2028 (the "Vesting Schedule"). The Options are exercisable in accordance with the Vesting Schedule and shall expire on June 24, 2035. |
Stock option (right to buy)
|
183,647 |
| 2025-06-01 | Malloy Lavell Juan II |
Director, Chairman and CEO |
Award↑
Filing footnotes — Stock option (right to buy) (Direct)
The stock options ("Options") were issued pursuant to Mr. Malloy's employment agreement dated June 15, 2024, under the Company's 2024 Omnibus Incentive Plan. Fifty percent (50%) of the Options vested on the issuance date, and twenty-five percent (25%) shall vest on each of March 6, 2026, and March 6, 2027 (the "Vesting Schedule"). The Options are exercisable in accordance with the Vesting Schedule and shall expire on March 5, 2035. |
Stock option (right to buy)
|
347,222 |
| 2025-06-01 | Jindal Chetan |
Chief Financial Officer |
Award↑
Filing footnotes — Stock option (right to buy) (Direct)
The stock options ("Options") were issued pursuant to Mr. Jindal's employment agreement dated December 30, 2024, under the Company's 2024 Omnibus Incentive Plan. Twenty-five percent (25%) of the Options vested on the issuance date, and twenty-five percent (25%) shall vest on each of March 6, 2026, March 6, 2027, and March 6, 2028 (the "Vesting Schedule"). The Options are exercisable in accordance with the Vesting Schedule and shall expire on March 5, 2035. |
Stock option (right to buy)
|
45,000 |
| 2025-06-01 | Leibovich Daniel |
Director, Chief Operating Officer |
Award↑
Filing footnotes — Stock option (right to buy) (Direct)
The stock options ("Options") were issued pursuant to Mr. Leibovich's employment agreement dated June 15, 2024, under the Company's 2024 Omnibus Incentive Plan. Fifty percent (50%) of the Options vested on the issuance date, and twenty-five percent (25%) shall vest on each of March 6, 2026, and March 6, 2027 (the "Vesting Schedule"). The Options are exercisable in accordance with the Vesting Schedule and shall expire on March 5, 2035. |
Stock option (right to buy)
|
347,222 |